infectious diseases

News

ViiV's Cabenuva enhances control of unsuppressed HIV

ViiV's long-acting injectable HIV drug, Cabenuva, has proved to be more effective than daily oral therapy for unsuppressed infections.

News

New York declares measles outbreak a "disaster emergency"

The governor of New York has said rising cases of measles constitute a statewide disaster emergency, as cases in neighbouring Pennsylvania pass 1,000.

News

Vaxcyte's pneumococcal jab exceeds expectations

Shares in Vaxcyte have rocketed on phase 3 trial data for its pneumococcal vaccine VAX-31 that suggests it could take on rivals from Pfizer and MSD.

News

Mirum puts Hepcludex in its sights with hep D readout

Gilead's Hepcludex was the first drug to be cleared in the US for hepatitis D in May, but a potential rival from Mirum Pharma is already looming.

News

Viral disease-carrying Aedes mosquito 'breeding in London'

Invasive Aedes mosquitoes and their larvae have been found in London, but the UKHSA says the risk to the public from diseases they can carry is low.

News

GSK pushes 'next-generation' mRNA flu shot into phase 3

Buoyed by positive data in a phase 2 trial, GSK will start a phase 3 programme for an mRNA-based flu shot targeting both HA and NA flu antigens.

ViiV's Cabenuva enhances control of unsuppressed HIV

New York declares measles outbreak a "disaster emergency"

Vaxcyte's pneumococcal jab exceeds expectations

Mirum puts Hepcludex in its sights with hep D readout

Viral disease-carrying Aedes mosquito 'breeding in London'

GSK pushes 'next-generation' mRNA flu shot into phase 3

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

infectious diseases

Editor's Picks